Chemokine inhibitors for HIV.
Eccleston
A
A
D019380:Anti-HIV Agents / Q000138:chemical synthesis*; D000906:Antibodies / Q000378:metabolism; D015704:CD4 Antigens / Q000378:metabolism; D054407:Chemokine CCL4; D018946:Chemokine CCL5 / Q000737:chemistry / Q000627:therapeutic use; D018925:Chemokines / Q000737:chemistry / Q000627:therapeutic use*; D019204:GTP-Binding Proteins / Q000378:metabolism; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1 / Q000235:genetics / Q000472:pathogenicity; D006801:Humans; D019402:Macrophage Inflammatory Proteins / Q000737:chemistry / Q000627:therapeutic use; D008565:Membrane Proteins / Q000378:metabolism; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D018121:Receptors, Cytokine / Q000037:antagonists & inhibitors*; D015728:Receptors, HIV / Q000037:antagonists & inhibitors* / Q000378:metabolism
D019380:Anti-HIV Agents; D000906:Antibodies; D015704:CD4 Antigens; D054407:Chemokine CCL4; D018946:Chemokine CCL5; D018925:Chemokines; D019402:Macrophage Inflammatory Proteins; D008565:Membrane Proteins; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D018121:Receptors, Cytokine; D015728:Receptors, HIV; D019204:GTP-Binding Proteins